Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Svetofor to place prefs on the St. Petersburg Currency Exchange

4/25/24 SVET

Ozon's turnover in Q1 increased by 88%

4/25/24 OZON

Ozon reported for 3 months of 2024 by IFRS

4/25/24 OZON

Board of Directors of Krasnoyarskenergosbyt recommended dividends

4/25/24 KRSB

SFI reported for 3 months of 2024 by RAS

4/25/24 SFIN

SPB Exchange reports 2023 by IFRS

4/25/24 SPBE

RusHydro wants to abandon the construction of a small HPP in Dagestan

4/25/24 HYDR

Ashinskiy Metzavod reported for 3 months of 2024 by RAS

4/25/24 AMEZ

VK may be headed by Stepan Kovalchuk

4/25/24 VKCO

Arsagera reported for 2023 by IFRS

4/24/24 ARSA